If you made any changes in Pure these will be visible here soon.

Personal profile

Overview

Probably all life processes are controlled by proteins. Proteins interact with each other and these interactions form giant networks which researchers only recently started to unravel. The primary research in my group is devoted to understanding of how proteins interact with themselves and with each other, and how their interactions are linked to diseases, such as viral infection, inflammation and cancer. If we understand the critical interactions causing the problems, we can change these interactions using carefully designed therapeutic drugs. One of the methods which we use is Nuclear Magnetic Resonance (NMR) spectroscopy, which allows us to look inside molecules, determining their shape and form, and mapping protein interaction interfaces. By observing the signals from each atom, the minute details of protein interactions can be revealed. Apart from looking at “useful” protein interactions, we are also interested in finding ways to prevent proteins from clumping together non-specifically, forming aggregates. We look at novel ways to prevent protein aggregation which would enable faster development of new protein-based biopharmaceuticals (such as antibodies) able to treat wide range of diseases, from autoimmune disorders to cancer. This may make injections of such new drugs less painful as well!

Biography

Alexander Golovanov is a Reader in the School of Chemistry, Faculty of Science and Engineering, working in the field of structural biology, and recently, in applications of light-coupled NMR spectroscopy for studies of processes triggered by light. 

Alexander graduated in 1988 from the Moscow Institute of Physics and Technology with the degree equivalent to MSc. He then joined NMR group in Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry and worked there with Professor Arseniev for a number of years. Alexander obtained his PhD in 1994 doing the project in the same group, and then became the member of staff, subsequently being promoted all the way from Junior to Senior Investigator.

In 1998 Alexander came to Leicester University (UK) to work as a Research Associate with Professor Gordon Roberts and Professor Lu-Yun Lian. In 2000 Alexander has moved to Manchester to be appointed as an Experimental Officer and NMR Manager in the University of Manchester Institute of Science and Technology. He was promoted to Senior Experimental Officer shortly after, in 2001. From 2006 Alexander moved to academic position in the Faculty of Life Sciences, The University of Manchester, and later transferred to the Department of Chemistry.

Research interests

Structural and dynamic studies of biological macromolecules (mainly proteins) and their interactions using NMR spectroscopy

Current Research

Studies of herpesviral proteins.

Herpes simplex virus 1 (HSV-1) causes diseases that range from painful skin lesions to keratitis and encephalitis. HSV-1 encodes an essential protein called ICP27 that is involved in a diversity of functions during viral infection. ICP27 has the intriguing ability to interact with viral mRNA and a multiplicity of host cell proteins, hijacking hem to benefit virus production. Thus, ICP27 could conceivably serve as a target for antiviral intervention. The future development of antivirals requires an understanding of how the cooperative assembly of these essential multicomponent complexes occurs and how the assembly is regulated. We will study the role of cooperativity in protein-protein and protein-RNA interactions mediated by ICP27 and characterize the binding interfaces of its complexes to determine how ICP27 is assembled in different complexes during viral infection, with the goal of revealing the molecular mechanism of its function. The structural information will be used to explore the role of interaction interface residues in ICP27 function during infection. ICP27 consists of a number of structured as well as intrinsically-unstructured domains, which participate in a large number of diverse protein-protein and protein-RNA interactions. We hypothesize that these interactions may be multi-site and therefore cooperative, mediated by regions that may be distant in the primary sequence. We postulate that transient interactions also are possible, especially when unfolded regions are involved. We hypothesize that at least some of ICP27's interactions are regulated by phosphorylation and/or arginine methylation. We will test these hypotheses in two specific aims: 1) To study the direct binding interfaces of ICP27 with cellular proteins and viral mRNA by generating shorter protein constructs in which structural stability is not perturbed, and expressing them in amounts sufficient for structural biology studie including traditional and novel Isotopically-Discriminated (IDIS) NMR spectroscopy as well as biophysical approaches. Cooperativity will be analyzed in interactions between short functional fragments of intrinsically unstructured N-terminal ICP27 and partners that interact within this region, including viral RNA and host cell proteins. In vitro post-translational modifications of ICP27 will be performed to explore how ICP27-multi-protein complex assembly is affected by phosphorylation and arginine methylation. We will also endeavor to perform structural studies of folded domains from the C-terminal part of ICP27 and to characterize interactions with its cellular protein partners. Because ICP27 undergoes a head-to-tail intramolecular interaction in vivo, a chimera containing appropriate fragments of the N- and C-termini could be created to study how these regions interact. 2) To explore the role of interaction interface residues in ICP27 function during viral infection, recombinant viruses will be constructed bearing point mutations at interaction interfaces and will be characterized for in vivo interactions and ICP27 functional activities and effects on viral infection.

Public Health Relevance

Herpes simplex virus 1 (HSV-1) causes diseases that range from recurrent painful skin lesions to blindness resulting from keratitis and morbidity and mortality due to encephalitis. Recent studies suggest that HSV-1 is a contributing factor in Alzheimer's disease. Further, HSV infection increases the risk for HIV acquisition. Current antivirals do not prevent or fully suppress HSV replication, which raises a major health concern. All human herpesviruses encode an essential multifunctional protein, which is called ICP27 in HSV. ICP27 has the intriguing ability to be involved in a diversity of functions during infection, involving hijacking host macromolecular complexes to benefit virus production. ICP27 interacts with viral mRNA and a multiplicity of host cell proteins and thus could be a target for antiviral intervention. How the cooperative assembly of ICP27 in these complexes occurs and how it is regulated, is unclear, but is required for future development of targeted antivirals directed at interaction interfaces. Further, what we learn about ICP27 may be helpful in designing drug targets for other herpesviruses, such as KSHV, EBV and HCMV, which encode ICP27 homologues.

 

Development of NMR methods for monitoring complex multiple protein-protein-ligand(s) interactions

 Modern physico-chemical and biochemical methods allow thorough characterisation of protein-protein interactions, by measuring some kind of "reporter signal" reflecting these interactions, or by capturing a snapshot - 3D structure of complex. But what if the interaction involves three or more components, which exhibit consecutive, cooperative or concurrent binding: how can we tell what happens dynamically with each existing component as new components are added? Limited number of reporter signals no longer can adequately represent such a complexity. Monitoring such dynamic and transitional events which all are elements of protein interaction networks is intrinsically difficult. Our current research is aimed at development of new isotopically discriminated (IDIS) NMR approaches enabling to monitor complex multi-component binding events in vitro (Golovanov et al., J. Amer. Chem. Soc 2007, 129(20):6528). We have recently also started developing methods how to monitor behaviour of pharmaceutically-relevant proteins in solution.

Reducing aggregation and self-association of pharmaceutically-relevant proteins

Increasing protein concentration in solution to the required level without causing aggregation and precipitation is often a challenging but important task in many fields, including of structural biology, and NMR spectroscopy. Recently the importance of this was further highlighted with the ever increasing number of proteins (such as monoclonal antibodies, mAbs) being approved as drugs by regulatory bodies. Increasing mAb formulation stability for long-term storage, and reducing its viscosity for injections, are the major tasks that pharmaceutical industry now faces. Earlier in our work we discovered that a simple addition of 50 mM L-Arginine and L-Glutamate to the sample buffer significantly increases protein solubility and suppresses proteolytic degradation.  The solubilisation protocol has been successfully used for a number of proteins with solubility problems, suggesting that it may be universally applicable. Recently, we demonstrated that arginine glutamate is also effective in increasing stability of mAb formulations.

Protein structure determination

NMR is a powerful method allowing determination of atomic-resolution structures of proteins. Some proteins fail to crystallize due to the presence of flexible tails or loops, and thus are not amenable for X-ray analysis: NMR is the method of choice in these cases. We use a combination of X-ray crystallography and NMR analysis to analyse comprehensively the structure and dynamics of proteins and cooperativity of their interactions with their targets – other proteins, DNA and RNA.

Teaching

Alexander Golovanov is a course coordinator of BIOL10551 and CHEM10520, also teaching on these courses.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 2 - Zero Hunger
  • SDG 3 - Good Health and Well-being
  • SDG 13 - Climate Action

Research Beacons, Institutes and Platforms

  • Manchester Institute of Biotechnology

Fingerprint

Dive into the research topics where Alexander Golovanov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or